Vorige

Y. van der Graaf

Hoogleraar klinische epidemiologie

Wetenschappelijk onderzoek

Publicaties

Key Publications:

  • Vernooij F, Heintz AP, Witteveen PO, van der Heiden-van der Loo M,Coebergh JW, van der Graaf Y. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.J Natl CancerInst. 2008 Mar 19;100(6):399-406.
  • Wassink AM, van der Graaf Y, Olijhoek JK, Visseren FL; SMART Study Group. Metabolic syndrome and the risk of new vascular events and allcause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. EurHeart J. 2008 Jan;29(2):213-23.
  • van Gorp MJ, Steyerberg EW, Van der Graaf Y.Decision guidelines for prophylactic replacement of Björk-Shiley convexo-concave heart valves: impact on clinical practice. Circulation. 2004 May 4;109(17):2092-6. Epub2004 Apr 12. Review.
  • Van Den Bosch MA, Kemmeren JM, Tanis BC, Mali WP, Helmerhorst FM,Rosendaal FR, Algra A, Van Der Graaf Y. The RATIO study: oral contraceptives and the risk of peripheral arterial disease in youngwomen. J Thromb Haemost. 2003 Mar;1(3):439-44.
  • Nederkoorn PJ, Elgersma OE, van der Graaf Y, Eikelboom BC, Kappelle LJ, Mali WP. Carotid artery stenosis: accuracy of contrast-enhanced MR angiography for diagnosis. Radiology. 2003 Sep;228(3):677-82.
  • Koerselman J, van der Graaf Y, de Jaegere PP, Grobbee DE. Coronary collaterals: an important and underexposed aspect of coronary artery disease. Circulation. 2003 May 20;107(19):2507-11. Review.
  • van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet.1996 Mar 16;347(9003):714-8.
  • van der Graaf Y, de Waard F, van Herwerden LA, Defauw J. Risk of strut fracture of Björk-Shiley valves. Lancet. 1992 Feb 1;339(8788):257-61.